DEBIOS Dx’s Post

Biotech startups often require substantial initial capital to support extensive research and development, clinical trials, and regulatory approvals before generating any revenue.   Our Investment Director, Michael Salako PhD MBA, recently spoke to Labiotech.eu, offering his advice to biotech startups trying to navigate the complex funding landscape.   When tackling the VC landscape, Michael advises biotech startups to be cautious and organised. “They should have a light touch non-confidential deck to send out and set the scene and a longer, more technical non-confidential deck that they can quickly talk to on a call if afforded the chance."   For more practical advice on choosing the right approach, read the full article here: https://rb.gy/smbt2h   #Biotech #StartUps #Funding #Fund #VentureBuilder

Josh Bilenker and Jeffrey Engelman's stealthy startup, Treeline Biosciences, secures an additional $421 million, marking a significant milestone in the biotech industry. The recent SEC filing unveils a funding round that places Treeline among the year's top biotech fundraisers, with a total of almost $900 million raised since its establishment in 2021. The latest filing hints at Treeline tapping into previously committed capital, showcasing strategic financial maneuvers. Stay tuned for more updates as Treeline continues to make waves in the biotech landscape. #Biotech #Funding #Innovation #smallmolecules #covalentmodifiers #moleculargluedegraders #allostericapproaches #machinelearning #AI #biotechnology #lifescience #lifesciences #Fundraise #900mtodate #startup #boardofdirectors ARCH Venture Partners KKR Aisling Capital OrbiMed GV (Google Ventures) #AILifeSciences Access Industries #421m

Recent data for venture investing in both biopharma and medtech are promising, showing increases year over year. VC dealmaking in the medtech sector is still on pace to surpass last year's numbers. According to PitchBook's latest Emerging Tech Research, startups generated $3.3 billion across 206 deals, with VC exits on the rise. Notable fundraises include BillionToOne's $130 million Series D and INSIGHTEC's $150 million round. Exciting opportunities are emerging in areas like sepsis testing and heart arrhythmia. For more details, check out the full article on PitchBook. BIOPHARMA financing is on fire in 2024, with nearly $78B raised in the first eight months, almost double last year's total. Despite a slight dip in August, this 91% surge highlights strong investor confidence and momentum in the industry. Exciting times ahead for biotech innovation! Read more on BioWorld for the full article. https://lnkd.in/gCyHYSvZ https://lnkd.in/gaXr7GU7 #MedTech #VentureCapital #Innovation #Healthcare #Investing #Innovation

🚨 We are pleased to announce that COBIOMIC has been recognized as an emerging startup by ENISA, highlighting our strength and innovation in the technology sector. This certification not only validates our quality and trust with the scientific community, but it also enhances our visibility and credibility within the business and technological ecosystem. ENISA's certification grants us access to participatory loans with favourable conditions, specifically designed for growing startups. This allows us to optimize our investments in research and development, facilitating effective expansion without the traditional financial constraints. Beyond financial support, this recognition is crucial for attracting additional strategic collaborations, expanding our operations, and consolidating our market presence. This achievement not only celebrates our commitment to excellence and innovation, but it also marks the beginning of a phase of accelerated growth and sustainable development for COBIOMIC. We are excited to face the new challenges and opportunities this recognition brings us. https://lnkd.in/gU7Su9Sh #ENISA #Innovation #Startup #Certification

Encouraging Signs for Medtech VC in Q1 2024 🚀 #medtech #venturecapital The medtech venture capital market roared back to life in the first quarter of 2024, with total investment reaching $3.3 billion according to the latest data from PitchBook. While deal volume remained historically low, this figure represents a strong rebound as investors piled into high-quality companies, signaling a keen focus on backing the most promising opportunities. #startup #funding The largest deal went to early cancer detection startup Freenome, which raised an impressive $254 million late-stage round led by Roche Venture Fund and Bain Capital Life Sciences. Other notable investments in the quarter included rounds for Impulse Dynamics, Mainstay Medical, Alamar Biosciences, and Medical Microinstruments. #biotechnology #oncology At $3.3 billion invested, Q1 2024 saw medtech VC activity reach a level not witnessed since Q4 2022 - providing a much-needed shot of optimism after a challenging few years for fundraising in the sector. However, it still lags behind the quarterly highs above $6 billion seen in 2021 during the VC boom years. #investment #venturecapital Looking at the overall landscape, Chicago's Tempus tops the list of top VC-backed medtech companies tracked by PitchBook, having raised a staggering $1.4 billion to date. #startups #entrepreneurs Read more: https://bit.ly/4dZoHH6

The Richi Entrepreneurs' 2024 Agenda of Zoom Panels for Early Stage Life Sciences Entrepreneurs! I am looking forward to hosting each of the panels below, and have already begun recruiting for them. We hope to make 2024 a successful year for early stage life sciences ventures everywhere! Hashtags: #venturecapital, #venture, #lifesciences, #biotech, #pharma, #healthcare, #medicaldevices, #startups, #funding, #investing. #startup, #lifesciences, #seedcapital, #seedfunding, #angelinvestment, #angel , #angelinvesting

Calling all early-stage Medtech companies - 2024 Applications are Open! Apply now for the Simbex Phase 0 MasterPlan™ Contest: https://hubs.ly/Q02Kq3D80 This year, we're doing it bigger than ever. First prize (valued at $50,000) will be announced at the MedTech Conference on October 15th, 2024! The Simbex Phase 0 MasterPlan™ Contest embodies our commitment to standing by innovators during the earliest, often toughest, phases of their journey. The prize value is significant not just in its monetary worth but in its ability to support these important innovations with early, consequential input toward achieving their eventual success. By participating, you’re not just entering a contest; you’re engaging a skilled and experienced partner that values and believes in your vision. #MedTech #MedicalDevices #Healthtech #Startups

🚀 A Launchpad for Biotech Innovations - The BioChallenge Pitch Competition 🚀 Struggling to make your mark in biotech? Discover how the BioChallenge Pitch Competition can elevate your startup! Join Kris Khalil, MBA, from NOBIC, and host James Zanewicz, JD, LLM, RTTP, on #BIOfromtheBAYOU as they dive into the competition’s impact and benefits. Applications due by August 9th, 2024 at 11:59pm CST. Tune in now! Link in comments 🔗 #BIOontheBAYOU #Biotech #Innovation #Startups

If you're an aspiring entrepreneur looking for potential problems or domains to tackle, you should check out the list and see if there's a request that resonates with you. From my perspective, I found the healthcare/biotech opportunities particularly inspiring and imperative given their urgency. - A Way to End Cancer - Foundation Models for Biological Systems - The Managed Service Organization Model for Healthcare - Eliminating Middlemen in Healthcare https://lnkd.in/g6CbW_8p #entrepreneurship #startups #YC #healthcare #biotech

Attention #MIF biotech startups (or those thinking of launching one): this webinar is for you! While the content will have a strong EU focus, there will be plenty of useful information for non-EU projects. https://lnkd.in/ehn57NQy